The hepatic artery supplies oxygen-rich blood, whereas the portal vein delivers blood enriched with nutrients. Their separate contributions allow the liver to support both tissue oxygenation and nutrient processing. Because these streams meet within hepatic sinusoids, clinicians must consider both vascular sources when evaluating hepatic perfusion rather than interpreting either supply in isolation.
Mixing in the hepatic sinusoids links incoming blood supplies to the liver’s metabolic and detoxification functions. Blood then passes toward central veins before leaving through the hepatic veins and inferior vena cava. This pathway provides a structural basis for understanding how upstream or downstream vascular changes can alter perfusion and affect liver function.
Changes in liver blood flow can influence more than oxygen delivery. Altered perfusion is relevant to portal hypertension, cirrhosis, and hepatic ischemia, and it may also modify how the liver processes substances. Examining the circulation therefore helps connect vascular abnormalities with disease progression, impaired tissue support, and changes in drug metabolism.
Clinicians assess hepatic perfusion and interpret vascular imaging by tracing how blood enters, traverses, and exits the liver. The dual inflow and venous drainage provide the framework for recognizing abnormal circulation. This evaluation can support assessment of portal hypertension, cirrhosis, hepatic ischemia, and other conditions in which vascular changes affect liver function.
During liver surgery and transplantation, understanding the vessels that supply and drain the organ is essential for evaluating hepatic perfusion. The hepatic artery, portal vein, hepatic veins, and inferior vena cava define the circulation that must be considered when clinicians assess these interventions. This vascular perspective also helps evaluate perfusion in surgical and transplant settings.
The liver’s circulation affects how blood reaches tissue responsible for metabolism and detoxification. If perfusion changes, the handling of drugs may also change, while altered flow can accompany or contribute to disease progression. For clinical interpretation, vascular findings should therefore be considered alongside metabolic function and the underlying liver disorder.